eXoZymes, Inc.
EXOZ
$7.80
-$0.82-9.51%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -7.97% | 17.02% | 46.97% | 59.92% | 88.22% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 22.37% | 35.91% | 56.49% | 91.78% | 93.43% |
| Operating Income | -22.37% | -35.91% | -56.49% | -91.78% | -93.43% |
| Income Before Tax | -27.68% | -50.17% | -38.07% | -73.76% | -84.08% |
| Income Tax Expenses | -- | -4,909.52% | -- | -- | -- |
| Earnings from Continuing Operations | -27.68% | -44.61% | -38.07% | -73.49% | -84.08% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -27.68% | -44.61% | -38.07% | -73.49% | -84.08% |
| EBIT | -22.37% | -35.91% | -56.49% | -91.78% | -93.43% |
| EBITDA | -23.01% | -36.86% | -58.84% | -96.41% | -98.82% |
| EPS Basic | -26.27% | -29.21% | -2.94% | -29.46% | -37.48% |
| Normalized Basic EPS | -26.24% | -34.14% | -2.90% | -29.68% | -37.60% |
| EPS Diluted | -26.27% | -29.21% | -2.94% | -29.46% | -37.48% |
| Normalized Diluted EPS | -26.24% | -34.14% | -2.90% | -29.68% | -37.60% |
| Average Basic Shares Outstanding | 1.09% | 11.92% | 34.15% | 34.01% | 33.88% |
| Average Diluted Shares Outstanding | 1.09% | 11.92% | 34.15% | 34.01% | 33.88% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |